Annals of Translational Medicine

Annals of Translational Medicine is an international, peer-reviewed, open access journal, aiming to provide multidisciplinary, comprehensive, and up-to-date information on translational medicine.

The T0 to T4 model of translational research emphasizes the continuity and interaction of the various stages involved, which is consistent with the vision of ATM. Therefore, ATM’s scope covers translational research phases from T0 to T4, including basic research, preclinical research, clinical research, clinical practice research, and health policy research. Of note, although ATM covers a wide range of research, those studies that are translational but have a focus other than the human body, medicine, or disease are not included in the scope of ATM.

While ATM focuses on many areas of translational medicine, there are several defining specialized sections that differentiate the aims and mission of the journal:

• Global Burden of Diseases—including those with high morbidity and mortality such as cancers, cardiovascular and neurological diseases, metabolic diseases, critical and emergent diseases.
• Omics Sciences—including genomics and genetics, epigenomics, transcriptomics, proteomics, metabolomics, medical bioinformatics, and radiomics.
• Data Sciences—including big biomedical data mining, machine learning, artificial intelligence, and translational imaging.
• Basic and Mechanism Sciences—including physiology, unknown etiology and pathology, mechanisms of disease and behavior, immunology such as immune-oncology and vaccine development.
• Biomarkers Sciences—including disease biomarkers mining, molecular diagnosis and therapies.
• Drug and Biomaterials Screening and Development—including disease modeling and simulation platforms, biomaterials and pharmaceutical formulation, clinical pharmacology such as pharmacokinetics and pharmacodynamics.
• Emerging Therapeutics—such as personalized therapy, precision therapy, cell, tissue and gene therapy, immunotherapy, immune checkpoint therapy, antibody therapy, and cancer transformation therapy.
• Emerging Medical Technology Innovation and Translation—such as gene editing technology, tissue engineering and regenerative medicine, RNA interference technology, medical device and diagnostic tool development, medical app, 3D printing, and mobile medicine.
• Data-Driven Clinical Practice and Policy Making—including health economics, clinical guidelines, health policy-making, and barriers to clinical practice and population adoption.
• Clinical Studies—including design, implementation, data management and analysis of case reports, observational studies, and phases 1–4 clinical trials.

Platform:

OvidSP

Publisher:

AME Publishing Company

Product Type:

Journal

Author:

AME

ISSN:

2305-5839

Specialty:

• Clinical Laboratory Science & Medical Technology
• Multidisciplinary Sciences

Language:

English

Update Frequency:

Semi-Monthly